Learning to distinguish progressive and non-progressive ductal carcinoma in situ
- 19 October 2022
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 22 (12) , 663-678
Abstract
Ductal carcinoma in situ (DCIS) is a non-invasive breast neoplasia that accounts for 25% of all screen-detected breast cancers diagnosed annually. Neoplastic cells in DCIS are confined to the ductal system of the breast, although they can escape and progress to invasive breast cancer in a subset of patients. A key concern of DCIS is overtreatment, as most patients screened for DCIS and in whom DCIS is diagnosed will not go on to exhibit symptoms or die of breast cancer, even if left untreated. However, differentiating low-risk, indolent DCIS from potentially progressive DCIS remains challenging. In this Review, we summarize our current knowledge of DCIS and explore open questions about the basic biology of DCIS, including those regarding how genomic events in neoplastic cells and the surrounding microenvironment contribute to the progression of DCIS to invasive breast cancer. Further, we discuss what information will be needed to prevent overtreatment of indolent DCIS lesions without compromising adequate treatment for high-risk patients.Keywords
This publication has 206 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Clonal evolution in cancerNature, 2012
- Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cellsProceedings of the National Academy of Sciences, 2011
- Human primary ductal carcinoma in situ (DCIS) subtype‐specific pathology is preserved in a mouse intraductal (MIND) xenograft modelThe Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cellsProceedings of the National Academy of Sciences, 2011
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ DiagnosisJNCI: Journal of the National Cancer Institute, 2010
- Immunohistochemical categorisation of ductal carcinoma in situ of the breastBritish Journal of Cancer, 2007
- Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1 -mutated basal-like breast cancerProceedings of the National Academy of Sciences, 2007